CD3 total cash interest is even bigger than that. The trust had $24.7mil on balance sheet on 30 June 22 The trust's interest in the LP represents $28.6mil cash on 30 June 22. = $0.70 cash per share on a look through basis
When the restructure gets voted down the LP will release cash that it can, being balance less US tax leakage and remaining commitments to managers (say $US5mil+ held back)
has to be a 25-30c distribution post meeting vote down.
Under the restructure it would appear that all of the sweet cash in CD1,2,3 would be sucked out to fund redemptions for tired CD4 holders, even though they committed to a 7-10 year unlisted investment (which is doing really really well).
VOTING ONLINE OPENS TOMORROW, IF YOU VOTE EARLY THE RE WILL SEE IT WONT'T GET UP AND HOPEFULLY PULL THE MEETING
CD3 Price at posting:
$1.45 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)